title: Prostate-specific antigen-negative prostate cancer recurrence?
abstract: We describe a patient with bone metastases occurring shortly after radical prostatectomy for organ-confined prostate cancer. The medical history and immunohistochemical findings suggested prostate cancer recurrence to the skeleton. Undetectable serum prostate-specific antigen levels, however, raised doubts about this diagnosis. A whole body (18)F-fluorodeoxyglucose positron emission tomography-computed tomography scan was obtained and revealed a right-sided breast cancer as the primary site of metastatic spread.
authors: Department of Urology, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany. Michael.Froehner@uniklinikum-dresden.de
authors: Michael
authors: M
authors: Froehner
authors: Nasreddin
authors: N
authors: Abolmaali
authors: Manfred P
authors: MP
authors: Wirth
mesh_terms: D000368:Aged; D001859:Bone Neoplasms / Q000097:blood / Q000000981:diagnostic imaging* / Q000556:secondary*; D018567:Breast Neoplasms, Male / Q000000981:diagnostic imaging* / Q000473:pathology*; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D064847:Multimodal Imaging; D049268:Positron-Emission Tomography; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood* / Q000601:surgery; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D017430:Prostate-Specific Antigen